NCT05495698View on ClinicalTrials.gov

Triple Therapy Convenience by the Use of One or Multiple Inhalers and Digital Support in Chronic Obstructive Pulmonary Disease

NARecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

December 13, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
CopdAdherence, Medication
Interventions
DRUG

single-inhaler triple therapy (Trimbow)

Patients in the intervention group will receive the triple therapy in one inhaler in stead of multiple inhalers. The actual medication is the same.

DEVICE

E-health application: Curavista app & FindAir e-device

Patients in intervention group 2 will receive Trimbow and will use the health app of Curavista and the smart-inhaler of FindAir

DRUG

multi-inhaler triple therapy (Qvar + Bevespi)

Patients in the intervention group will receive the triple therapy in multiple inhalers. The actual medication is the same.

Trial Locations (1)

3045PM

RECRUITING

Franciscus Gasthuis & Vlietland, Rotterdam

All Listed Sponsors
lead

Franciscus Gasthuis

OTHER